Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sonia Hernandez-Diaz, D.P.H., M.D.

Co-Author

This page shows the publications co-authored by Sonia Hernandez-Diaz and Yanmin Zhu.
Connection Strength

0.961
  1. Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse. Am J Obstet Gynecol MFM. 2021 03; 3(2):100304.
    View in: PubMed
    Score: 0.228
  2. Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2021 03; 224(3):290.e1-290.e22.
    View in: PubMed
    Score: 0.224
  3. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ. 2020 May 20; 369:m1494.
    View in: PubMed
    Score: 0.219
  4. Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States. JAMA Psychiatry. 2022 Mar 01; 79(3):232-242.
    View in: PubMed
    Score: 0.062
  5. Validity of claims-based algorithms to identify neurodevelopmental disorders in children. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1635-1642.
    View in: PubMed
    Score: 0.060
  6. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021 02 10; 372:n102.
    View in: PubMed
    Score: 0.058
  7. Chronic prescription opioid use in pregnancy in the United States. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):504-513.
    View in: PubMed
    Score: 0.057
  8. Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations. JAMA. 2020 01 28; 323(4):372-374.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.